Edition:
United States

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

6.36USD
1:01pm EST
Change (% chg)

$0.20 (+3.25%)
Prev Close
$6.16
Open
$6.05
Day's High
$6.37
Day's Low
$6.04
Volume
15,927
Avg. Vol
14,884
52-wk High
$8.14
52-wk Low
$2.81

Select another date:

Mon, Oct 16 2017

BRIEF-Aeglea Biotherapeutics announces clinical collaboration with Merck

* Aeglea Biotherapeutics announces clinical collaboration with Merck to evaluate the combination of Aeglea’S AEB1102 (pegzilarginase) with Merck's Keytruda® (pembrolizumab) for the treatment of small cell lung cancer

Select another date: